Dr Reddy's Laboratories Q2 2025 GAAP EPS $0.18 Compared To $0.21 YoY, Sales $957.00M Compared To $821M YoY
Dr Reddy's Laboratories Q2 2025 GAAP EPS $0.18 Compared To $0.21 YoY, Sales $957.00M Compared To $821M YoY
Dr. Reddy's Laboratories 2025財年第二季度按照美國通用會計準則每股收益爲$0.18，同比下降至$0.21，銷售額爲95700萬美元，同比增至82100萬美元
Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.18 per share which missed the analyst consensus estimate of $84.03 by 99.79 percent. This is a 14.29 percent decrease over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $957.00 million which missed the analyst consensus estimate of $76.49 billion by 98.75 percent. This is a 16.57 percent increase over sales of $821.00 million the same period last year.
Dr Reddy's Laboratories(紐交所:RDY)報告每股盈利爲0.18美元，低於分析師預期的84.03美元，降幅達99.79%。 這較去年同期的每股盈利0.21美元下降了14.29%。 公司報告的季度銷售額爲9,5700萬美元，較分析師預期的764.9億美元低了98.75%。 與去年同期的8,2100萬美元相比，這是銷售額增長了16.57%。
熱門討論
科技巨頭財報季如火如荼，英偉達壓軸會表現如何？
週四， $亞馬遜 (AMZN.US)$ 該公司報告第四季度調整後每股收益爲1.86美元，高於1.50美元的預期，營業收入爲1877.9亿美元，高於1873.2亿美元的預期。公司預測下一季度營收將低於華爾街的預期，預計本季度最多爲1550亿美元，而分析師們希望達到1580亿美元。
Moo Earnings
02/02 12:39
亞馬遜收益預覽：通過猜測開盤價格獲得獎勵！